Orofacial antinociceptive activity of (S)-(-)-perillyl alcohol in mice: a randomized, controlled and triple-blind study.

Autor: Tomaz-Morais JF; Post-graduate Program in Dentistry, Federal University of Paraíba, João Pessoa, Paraíba, Brazil., Braga RM; Post-graduate Program in Dentistry, Federal University of Paraíba, João Pessoa, Paraíba, Brazil., de Sousa FB; Post-graduate Program in Dentistry, Federal University of Paraíba, João Pessoa, Paraíba, Brazil., de Sousa DP; Post-graduate Program in Dentistry, Federal University of Paraíba, João Pessoa, Paraíba, Brazil., deM Pordeus LC; Post-graduate Program in Dentistry, Federal University of Paraíba, João Pessoa, Paraíba, Brazil., de Almeida RN; Post-graduate Program in Dentistry, Federal University of Paraíba, João Pessoa, Paraíba, Brazil., de Castro RD; Post-graduate Program in Dentistry, Federal University of Paraíba, João Pessoa, Paraíba, Brazil. Electronic address: ricardodiasdecastro@pq.cnpq.br.
Jazyk: angličtina
Zdroj: International journal of oral and maxillofacial surgery [Int J Oral Maxillofac Surg] 2017 May; Vol. 46 (5), pp. 662-667. Date of Electronic Publication: 2017 Feb 21.
DOI: 10.1016/j.ijom.2017.01.024
Abstrakt: This study investigated the antinociceptive effects of (S)-(-)-perillyl alcohol (PA) on orofacial nociception in Swiss male mice using formalin-, capsaicin-, and glutamate-induced pain tests. For each test, eight animals per group were pre-treated intraperitoneally by a blinded investigator with PA (50 or 75mg/kg), morphine, or vehicle (saline+0.2% Tween 80). The treatment was performed before the induction of orofacial nociception by injecting formalin, capsaicin, or glutamate solution into the right area of the upper lip. The orofacial nociceptive behaviour was timed in all tests by an investigator who was blinded to the treatments. The statistical analysis was performed using confidence intervals (CI), the effect size, and power. PA blocked the orofacial nociceptive behaviour at both doses tested (P<0.05) similarly to morphine (P>0.05), in all tests. The effect size was high in the phase 1 formalin test for 50mg/kg PA (95% CI 0.48-2.31, power 84.6%) and 75mg/kg PA (95% CI 0.82-2.76, power 96.2%), in phase 2 for 75mg/kg PA (95% CI 0.44-2.26, power 82.3%), and in the glutamate test for 75mg/kg PA (95% CI 1.11-3.16, power 99.2%). These findings show strong evidence for the antinociceptive properties of PA in the orofacial region.
(Copyright © 2017 International Association of Oral and Maxillofacial Surgeons. Published by Elsevier Ltd. All rights reserved.)
Databáze: MEDLINE
Externí odkaz: